Ayala Pharmaceuticals, Inc.
Net BuyingAYLA·US·🇺🇸 US
67%buys·33%sales
95 transactions$31.9MTotal buys·14 buys
$1.0MTotal sells·7 sells
1313 insiders
Last: Jan 19, 2023
Ayala Pharmaceuticals, Inc. (AYLA) has recorded 95 insider transactions from 13 insiders. Total insider buying volume stands at $31.9M, while total selling volume is $1.0M. Overall insider sentiment is bullish (67% purchases).
Ayala Pharmaceuticals, Inc. (AYLA) has recorded 95 insider operations, including 14 open-market purchases ($31.9M), 7 sales ($1.0M) and 74 other operations (stock option exercises, grants, tax dispositions, donations). The insider sentiment is bullish (67% purchases).
Among the most active insiders are Mamluk Roni (CEO), Yossi Maimon (CFO) & Gordon Gary B. (C SUITE), with respectively 62, 48, 17 transactions.
Data sourced from regulatory filings (SEC Form 4, AMF, BaFin, FI, and other European authorities).
Advanced analytics coming soon
Price impact analysis, win rates, and predictive signals are being developed.